2019). Additionally, the expression of FK506‐binding protein 4 (FKBP4) is significantly altered in the CSF and midbrain dopaminergic neurons (mDAs) of patients with the GBA1 variant Parkinson's disease (GBA1‐PD) (Kojima et al. 2024). This evidence concerns the gene GBA1 and Parkinson disease.